Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
12.97B | 12.82B | 12.14B | 11.61B | 11.62B | 11.55B | Gross Profit |
4.21B | 4.22B | 3.82B | 3.40B | 3.65B | 3.56B | EBIT |
2.05B | 2.09B | 1.60B | 1.34B | 1.80B | 1.69B | EBITDA |
2.66B | 2.72B | 2.32B | 2.05B | 2.45B | 2.31B | Net Income Common Stockholders |
859.61M | 936.34M | 691.53M | 768.19M | 978.45M | 773.64M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
355.74M | 846.00M | 391.67M | 321.78M | 484.21M | 345.06M | Total Assets |
17.43B | 17.29B | 16.89B | 16.93B | 17.12B | 16.99B | Total Debt |
11.84B | 12.07B | 11.12B | 11.82B | 11.98B | 11.19B | Net Debt |
11.50B | 11.27B | 10.74B | 11.58B | 11.51B | 10.87B | Total Liabilities |
14.79B | 15.19B | 14.15B | 14.70B | 14.75B | 14.09B | Stockholders Equity |
926.00M | 121.12M | 1.06B | 712.33M | 755.51M | 1.38B |
Cash Flow | Free Cash Flow | ||||
1.76B | 1.47B | 1.49B | 961.14M | 1.29B | 1.30B | Operating Cash Flow |
2.34B | 2.02B | 2.06B | 1.56B | 1.93B | 1.98B | Investing Cash Flow |
-718.36M | -771.43M | -771.80M | -630.35M | -784.73M | -825.37M | Financing Cash Flow |
-1.52B | -816.94M | -1.17B | -1.12B | -1.08B | -1.85B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $16.73B | 25.02 | 4.36% | 2.02% | ― | ― | |
75 Outperform | $8.22B | 27.32 | 26.11% | 0.36% | 8.52% | 10.36% | |
71 Outperform | $15.78B | 11.36 | 38.12% | ― | -1.79% | -41.85% | |
70 Outperform | $12.15B | 10.62 | 18.35% | 0.42% | 9.73% | 51.87% | |
68 Neutral | $12.22B | 25.04 | 25.33% | 0.54% | 11.21% | 30.38% | |
64 Neutral | $10.32B | 13.63 | 260.92% | ― | 5.11% | 14.28% | |
54 Neutral | $5.24B | 3.27 | -45.39% | 2.80% | 16.77% | -0.07% |
On May 23, 2025, DaVita Inc. completed a private offering of $1.0 billion in 6.750% Senior Notes due 2033. The company received approximately $986 million in net proceeds, which it plans to use primarily to repay $830 million in outstanding credit facility borrowings and cover associated costs, with the remainder allocated for general corporate purposes. The notes are unsecured senior obligations and come with specific covenants and redemption options, but they are not registered under the Securities Act and will not be listed on any securities exchange.
The most recent analyst rating on (DVA) stock is a Hold with a $145.00 price target. To see the full list of analyst forecasts on DaVita stock, see the DVA Stock Forecast page.
On May 20, 2025, DaVita Inc. announced the upsize and pricing of its private offering of 6.750% senior notes due 2033, increasing the aggregate principal amount from $750 million to $1 billion. The proceeds from this offering are intended to repay outstanding credit facility borrowings and cover related expenses, with any remaining funds used for general corporate purposes. This strategic financial move is expected to close on May 23, 2025, and aims to strengthen DaVita’s financial position and operational flexibility.
The most recent analyst rating on (DVA) stock is a Sell with a $145.00 price target. To see the full list of analyst forecasts on DaVita stock, see the DVA Stock Forecast page.
On May 20, 2025, DaVita Inc. announced the initiation of a private offering of $750 million in senior notes due in 2033, with proceeds intended to repay existing credit facilities and cover associated costs, with any remaining funds allocated for general corporate purposes. This strategic financial move is designed to strengthen DaVita’s financial position, potentially impacting its operations and industry standing, while also reflecting its ongoing commitment to financial flexibility and growth.
The most recent analyst rating on (DVA) stock is a Sell with a $145.00 price target. To see the full list of analyst forecasts on DaVita stock, see the DVA Stock Forecast page.